FDA 483 - Arifulla Khan MD - June 11, 2014
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Arifulla Khan, M.D., a clinical investigator in Bellevue, WA, was cited for significant deficiencies in conducting clinical trials. The inspection revealed failures to adhere to investigational plans, including issues with contradictory subject eligibility documentation and improper management of investigational product non-compliance. Additionally, the firm failed to obtain proper informed consent and maintain accurate case histories, leading to critical data discrepancies.
ID · 86776fd3-10ae-4872-aa64-fce0d73af6b9